Basal 18F-FDG PET/CT in follicular lymphoma: a comparison of metabolic and clinical variables in the prognostic assessment / Valor de la 18F-FDG PET/TC basal en el linfoma folicular: comparación de las variables metabólicas y clínicas en la valoración pronóstica

Aim. To analyze the relationship of clinical variables related to prognosis and tumor burden, with metabolic variables obtained in the staging 18F-FDG PET/CT, and their value in the prognosis in follicular lymphoma (FL). Methods. 82 patients with FL, a 18F-FDG PET/CT at diagnosis and a follow-up for a minimum of 12 months, were retrospectively enrolled in the present study. Clinical variables (Tumor grade, Follicular Lymphoma International Prognostic Index (FLIPI) and Tumor burden) were evaluated. Metabolic variables such as SUVmax in the highest hypermetabolic lesion, extralymphatic locations, number of involved lymph node locations, bone marrow (BM) involvement, PET stage and diameter of the biggest hypermetabolic lesion, were analyzed in order to establish a PET score and classify the studies in low, intermediate and high metabolic risk. Clinical and metabolic variables (included metabolic risk) were compared. The relation among all variables and disease-free survival (DFS) was studied. Results. The 28% of patients had a high-grade tumor. The 30.5% had FLIPI risk low, 29.3% intermediate y 40.2% high. The 42.7% presented a high tumor burden. The PET/CT was positive in 94% of patients. The tumor grade did not show significant relation with metabolic variable. FLIPI risk and tumor burden showed statistical relations with the SUV max and the PET score (p<0.008 and p=0.003 respectively). With respect to DFS, significant differences were detected for the PET stage and FLIPI risk (p=0.015 and p=0.047 respectively). FLIPI risk was the only significant predictor in Cox regression analysis, with a Hazard Ratio of 5.13 between high risk and low risk. Conclusion. The present research highlights the significant relation between metabolic variables obtained with FDG PET/CT and clinical variables although their goal as an independent factor of prognosis was not demonstrated in the present work (AU)

Objetivo. Analizar la relación entre las variables clínicas relativas al pronóstico y la carga tumoral y las variables obtenidas en la 18F-FDG PET/TC de estadificación, así como su valor pronóstico para el linfoma folicular (LF). Métodos. Se realizó un estudio retrospectivo de 82 pacientes con LF, 18F-FDG PET/TC en el momento del diagnóstico y seguimiento mínimo de 12 meses. Se evaluaron las variables clínicas (grado tumoral, Índice pronóstico internacional para el linfoma folicular (FLIPI) y carga tumoral). Se analizaron las variables metabólicas tales como SUVmax en las lesiones más hipermetabólicas, localizaciones extralinfáticas, número de localizaciones ganglionares afectas, afectación de la médula ósea, estadio PET y diámetro de la lesión hipermetabólica de mayor tamaño, a fin de establecer una puntuación PET y clasificar los estudios en riesgo bajo, medio y elevado. Se compararon las variables clínicas y metabólicas (incluyendo el riesgo metabólico) y se estudió la relación entre todas las variables y la supervivencia libre de enfermedad (SLE). Resultados. El 28% de los pacientes tenían un tumor de alto grado. El 30,5% tenía un riesgo bajo de FLIPI, el 29,3% un grado intermedio y el 40,2% un riesgo elevado. El 42,7% presentó una elevada carga tumoral. La PET/TC fue positiva en el 94% de los pacientes. El grado del tumor no reflejó una relación significativa con la variable metabólica. El riesgo de FLIPI y la carga tumoral guardaron relaciones estadísticas con SUVmax y la puntuación PET (p<0,008 y p=0,003, respectivamente). Con respecto a la SLE, se detectaron diferencias significativas para el estadio PET y el riesgo FLIPI (p=0,015 y p=0,047, respectivamente). El riesgo FLIPI fue el único factor predictivo significativo en el análisis de regresión, con un cociente de riesgo instantáneo (HR) de 5,13 entre alto y bajo riesgo. Conclusión. La presente investigación resalta la considerable relación entre las variables metabólicas obtenidas con FDG PET/TC y las variables clínicas, aunque su objetivo como factor independiente de pronóstico no ha sido demostrado en el presente estudio (AU)

Basal (18)F-FDG PET/CT in follicular lymphoma: A comparison of metabolic and clinical variables in the prognostic assessment.

AIM: To analyze the relationship of clinical variables related to prognosis and tumor burden, with metabolic variables obtained in the staging (18)F-FDG PET/CT, and their value in the prognosis in follicular lymphoma (FL). METHODS: 82 patients with FL, a (18)F-FDG PET/CT at diagnosis and a follow-up for a minimum of 12 months, were retrospectively enrolled in the present study. Clinical variables (Tumor grade, Follicular Lymphoma International Prognostic Index (FLIPI) and Tumor burden) were evaluated. Metabolic variables such as SUVmax in the highest hypermetabolic lesion, extralymphatic locations, number of involved lymph node locations, bone marrow (BM) involvement, PET stage and diameter of the biggest hypermetabolic lesion, were analyzed in order to establish a PET score and classify the studies in low, intermediate and high metabolic risk. Clinical and metabolic variables (included metabolic risk) were compared. The relation among all variables and disease-free survival (DFS) was studied. RESULTS: The 28% of patients had a high-grade tumor. The 30.5% had FLIPI risk low, 29.3% intermediate y 40.2% high. The 42.7% presented a high tumor burden. The PET/CT was positive in 94% of patients. The tumor grade did not show significant relation with metabolic variable. FLIPI risk and tumor burden showed statistical relations with the SUV max and the PET score (p<0.008 and p=0.003 respectively). With respect to DFS, significant differences were detected for the PET stage and FLIPI risk (p=0.015 and p=0.047 respectively). FLIPI risk was the only significant predictor in Cox regression analysis, with a Hazard Ratio of 5.13 between high risk and low risk. CONCLUSION: The present research highlights the significant relation between metabolic variables obtained with FDG PET/CT and clinical variables although their goal as an independent factor of prognosis was not demonstrated in the present work.

[Colon lymphoma as a cause of fever of unknown origin]. / Linfoma de colon como causa de fiebre de origen desconocido.

We present a case of a 49 year old man who presented with a 2 month history of fever, nausea vomiting and weight loss (10 kg). He was admitted to the Hospital with the diagnosis of fever of unknown origin. A CT scan showed a wide thickening of the colonic wall (transverse colon and hepatic flexure) suggesting a colon tumor, and a solid mass in the left liver lobe. A colonoscopy was performed showing a circumferential neoplasm and biopsies were taken. The histopathology was informed as a diffuse large B cell lymphoma. Primary colon lymphoma is a rare gastrointestinal tumor that represents less than 1% of the gastrointestinal lymphomas. Based on this case, we reviewed the most recent articles about gastrointestinal lymphomas.

Linfoma de colon como causa de fiebre de origen desconocido / Colon lymphoma as a cause of fever of unknown origin

Presentamos el caso de un varón de 49 años que presentó un cuadro de fiebre de dos meses de evolución, acompañado de nauseas, vómitos y perdida de 10 kilogramos de peso. Con el diagnostico de fiebre de origen desconocido ingresó. En la TAC abdominal se objetivó un extenso engrosamiento de la pared de colon transverso y ángulo hepático, sugestivo de neoplasia de colon y una gran lesión sólida en lóbulo hepático izquierdo. Se realizó una colonoscopia observándose una neoplasia circunferencial, tomándose biopsias. La anatomía patológica fue informada de linfoma de células grandes difuso tipo B. El linfoma primario de colon es un tumor muy poco frecuente del tracto gastrointestinal, no superando el 1% en las series consultadas. Basándonos en este caso se hizo una revisión de los artículos más recientes sobre linfoma gastrointestinal

We present a case of a 49 year old man who presented with a 2 month history of fever, nausea vomiting and weight loss (10 kg). He was admitted to the Hospital with the diagnosis of fever of unknown origin. A CT scan showed a wide thickening of the colonic wall (transverse colon and hepatic flexure) suggesting a colon tumor, and a solid mass in the left liver lobe. A colonoscopy was performed showing a circumferential neoplasm and biopsies were taken. The histopathology was informed as a diffuse large B cell lymphoma. Primary colon lymphoma is a rare gastrointestinal tumor that represents less than 1% of the gastrointestinal lymphomas. Based on this case, we reviewed the most recent articles about gastrointestinal lymphomas

Leucemia secundaria al tratamiento del carcinoma testicular / Leukemia secondary to the treatment of testicular carcinoma

No disponible

Linfoma marginal esplénico, diagnóstico por la esplenectomía / Splenic marginal lymphoma, diagnosis made throught splenectomy

No disponible

Hipoglucemia severa como primera manifestación de una leucemia linfoblástica Burkitt-like / Acute hypoglucaemia as first manifestation of a Burkitt-like myelogeneous leukemia

No disponible